People

montero-fernando
Fernando Montero, PhD
Columbia University - Chief T32 Postdoctoral Research Fellow, HIV Center for Clinical and Behavioral Studies
Columbia University - Postdoctoral Research Fellow, HEALing Communities Study NY
Education
PhD, Sociocultural Anthropology, Columbia University
BA, History, Princeton University
Research Interests
Narcotics supply, people who sell drugs, supply-side harm reduction, substance use, synthetic narcotics, HIV/HCV, skin wounds and soft-tissue infections, xylazine, fentanyl
BIO
Fernando Montero is a medical anthropologist. His main project involves developing the field of “supply-side harm reduction” in the United States by incorporating people who sell drugs into harm reduction research and intervention. His mixed-methods research combines the study of drug use and the study of drug selling to better understand transformations to the street drug supply in the United States, especially the emergence of synthetic sedatives (fentanyl and xylazine) and stimulants (crystal methamphetamine). He focuses particularly on contemporary changes in the risk environment for HIV, HCV, soft-tissue infections, and fatal overdose among people who use drugs in Philadelphia and the wider Rust Belt region. One of the central questions guiding his current research is why the opioid overdose epidemic is increasingly affecting Black Americans following almost three decades in which it predominantly affected White working-class Americans. He is also conducting a long-term ethnographic study of the War on Drugs and militarization in the Afro-Indigenous region of Moskitia on the Caribbean Coast of Nicaragua and Honduras.
Projects
Principal Investigator, Towards Supply-Side Harm Reduction: Formative Research for Incorporating Latinx People Who Sell Drugs into Harm Reduction Interventions. Active
Publications

Recent

Karandinos G, Unick J, Ondocsin J, Holm N, Mars S, Montero F, Rosenblum D, Ciccarone D (2024).
Decrease in injection and rise in smoking and snorting of heroin and synthetic opioids, 2000-2021
Drug and Alcohol Dependence, 263, 111419. doi: 10.1016/j.drugalcdep.2024.111419.

Zhu DT, Friedman J, Bourgois P, Montero F, Tamang S (2023).
The emerging fentanyl-xylazine syndemic in the USA: Challenges and future directions
Lancet, 402 (10416), 1949-1952. doi: 10.1016/S0140-6736(23)01686-0. PMCID: PMC10842070.

Montero F, Bourgois P, Friedman J (2022).
Potency-enhancing synthetics in the drug overdose epidemic: Xylazine (“Tranq”), fentanyl, methamphetamine, and the displacement of heroin in Philadelphia and Tijuana
Journal of Illicit Economies and Development, 4 (2), 204-222. doi: 10.31389/jied.122. PMCID: PMC10065983.

Friedman J, Montero F, Bourgois P, Wahbi R, Dye D, Goodman-Meza D, Shover C (2022).
Xylazine spreads across the US: A growing component of the increasingly synthetic and polysubstance overdose crisis
Drug and Alcohol Dependence, 233, 109380. doi: 10.1016/j.drugalcdep.2022.109380. PMCID: PMC9128597.

Mars SG, Bourgois P, Karandinos G, Montero F, Ciccarone D (2016).
The textures of heroin: User perspectives on “black tar” and powder heroin in two U.S. cities
Journal of Psychoactive Drugs, 48 (4), 270-278. doi: 10.1080/02791072.2016.1207826. PMCID: PMC5027195.

Dr. Montero's Academia Profile